These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7882187)

  • 21. Possible role of the adrenergic mechanism in gastric inhibitory polypeptide- and glucagon-like peptide-1 (7-36) amide-induced insulin release in the rat.
    Ikeda T; Ochi H; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Mashiba H
    Metabolism; 1993 Feb; 42(2):209-13. PubMed ID: 8386288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB; Buchan AM; Kofod H
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
    Rocca AS; Brubaker PL
    Endocrinology; 1999 Apr; 140(4):1687-94. PubMed ID: 10098504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of glucagon-like peptide-1 on insulin secretion.
    Shima K; Hirota M; Ohboshi C
    Regul Pept; 1988 Aug; 22(3):245-52. PubMed ID: 3051138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells.
    Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE
    J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
    Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of endomorphin on somatostatin secretion in the isolated perfused rat stomach.
    Lippl F; Schusdziarra V; Allescher HD
    Neuropeptides; 2001; 35(5-6):303-9. PubMed ID: 12030816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.
    Ahrén B; Hughes TE
    Endocrinology; 2005 Apr; 146(4):2055-9. PubMed ID: 15604213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vagally induced release of gastrin, somatostatin and bombesin-like immunoreactivity from perfused rat stomach. Effect of stimulation frequency and cholinergic mechanisms.
    Madaus S; Bender H; Schusdziarra V; Kehe K; Munzert G; Weber G; Classen M
    Regul Pept; 1990 Oct; 30(3):179-92. PubMed ID: 1979685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
    Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
    Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vagus, gastric inhibitory polypeptide, and HCl on gastrin and somatostatin release from perfused pig antrum.
    Holst JJ; Jensen SL; Knuhtsen S; Nielsen OV; Rehfeld JF
    Am J Physiol; 1983 May; 244(5):G515-22. PubMed ID: 6133453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon.
    Plaisancie P; Bernard C; Chayvialle JA; Cuber JC
    Endocrinology; 1994 Dec; 135(6):2398-403. PubMed ID: 7988423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
    Roberge JN; Brubaker PL
    Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.
    Gromada J; Bokvist K; Ding WG; Holst JJ; Nielsen JH; Rorsman P
    Diabetes; 1998 Jan; 47(1):57-65. PubMed ID: 9421375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
    Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
    Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of vasoactive intestinal peptide, peptide histidine isoleucine and growth hormone-releasing factor-40 on bombesin-like immunoreactivity, somatostatin and gastrin release from the perfused rat stomach.
    Schusdziarra V; Schmid R; Bender H; Schusdziarra M; Rivier J; Vale W; Classen M
    Peptides; 1986; 7(1):127-33. PubMed ID: 2872659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
    de Heer J; Rasmussen C; Coy DH; Holst JJ
    Diabetologia; 2008 Dec; 51(12):2263-70. PubMed ID: 18795252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.